Literature DB >> 27277761

Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.

Satoru Kobayashi1, Yoko Karube2, Morimichi Nishihira1, Takashi Inoue1, Osamu Araki1, Sumiko Maeda1, Tetsu Sado1, Yuji Matsumura3, Masayuki Chida1.   

Abstract

OBJECTIVE: Acute exacerbation (AE) of idiopathic interstitial pneumonia (IP) is a potentially fatal postoperative complication following lung cancer resection. Postoperative pyothorax (PP) following development of a bronchopleural fistula (BPF) after lung surgery induces continuous inflammation and may affect the occurrence of AE. We investigated the relationship between AE and PP in patients who underwent pulmonary resection for lung cancer.
METHODS: A total of 941 patients who underwent lung resection due to primary lung cancer from 2006 to 2015 at our hospital were investigated.
RESULTS: Of the 941 enrolled patients, 137 (14.6 %) had idiopathic IP and were predominantly male (p < 0.01). Pathological stage Ia and adenocarcinoma were observed at significantly high rates in the non-IP group (p < 0.01). Patients with IP showed a tendency for a higher percentage of PP (p = 0.054). Of the 137 patients with IP, 17 (12.4 %) showed postoperative AE. Furthermore, PP was observed in three cases in the AE(+) group and two in the AE(-) group. PP had a correlation with a significantly higher incidence of AE (p = 0.007).
CONCLUSION: PP was found to be a significant risk factor for postoperative AE in lung cancer patients undergoing a pulmonary resection. Since IP itself is likely a risk factor for PP, prevention of BPF is important for patients with IP, as it can lead to PP.

Entities:  

Keywords:  Acute exacerbation; Interstitial pneumonia; Lung cancer; Pyothorax

Mesh:

Year:  2016        PMID: 27277761     DOI: 10.1007/s11748-016-0665-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  13 in total

Review 1.  CXC chemokines in vascular remodeling related to pulmonary fibrosis.

Authors:  Robert M Strieter; John A Belperio; Michael P Keane
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

Review 2.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

3.  Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.

Authors:  Masayuki Chida; Shuichi Ono; Yasushi Hoshikawa; Takashi Kondo
Journal:  Eur J Cardiothorac Surg       Date:  2008-08-21       Impact factor: 4.191

4.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

5.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 6.  Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review.

Authors:  Masayuki Chida; Satoru Kobayashi; Yoko Karube; Makio Hayama; Motohiko Tamura; Hiromi Ishihama; Takeshi Oyaizu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2012-03-24       Impact factor: 1.520

7.  Experience with fatal interstitial pneumonia after operation for lung cancer.

Authors:  T Tanita; M Chida; Y Hoshikawa; M Handa; M Sato; M Sagawa; S Ono; Y Matsumura; T Kondo; S Fujimura
Journal:  J Cardiovasc Surg (Torino)       Date:  2001-02       Impact factor: 1.888

8.  Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.

Authors:  Toshihiko Sato; Atsushi Watanabe; Haruhiko Kondo; Masato Kanzaki; Kenichi Okubo; Kohei Yokoi; Kazuya Matsumoto; Takashi Marutsuka; Hirohiko Shinohara; Satoshi Teramukai; Kazuma Kishi; Masahito Ebina; Yukihiko Sugiyama; Okumora Meinoshin; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2014-09-18       Impact factor: 5.209

Review 9.  IPF: new insight on pathogenesis and treatment.

Authors:  S Harari; A Caminati
Journal:  Allergy       Date:  2010-02-01       Impact factor: 13.146

10.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.

Authors:  Toshihiko Sato; Satoshi Teramukai; Haruhiko Kondo; Atsushi Watanabe; Masahito Ebina; Kazuma Kishi; Yoshitaka Fujii; Tetsuya Mitsudomi; Masahiro Yoshimura; Tomohiro Maniwa; Kenji Suzuki; Kazuhiko Kataoka; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

View more
  5 in total

Review 1.  Risk factor of bronchopleural fistula after general thoracic surgery: review article.

Authors:  Masaya Okuda; Tetsuhiko Go; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-10-12

2.  Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan.

Authors:  Shunsuke Endo; Norihiko Ikeda; Takashi Kondo; Jun Nakajima; Haruhiko Kondo; Yoshihisa Shimada; Masami Sato; Shinichi Toyooka; Yoshinori Okada; Yukio Sato; Ichiro Yoshino; Morihito Okada; Meinoshin Okumura; Masayuki Chida; Eriko Fukuchi; Hiroaki Miyata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-10-16

3.  Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection.

Authors:  Satoru Kobayashi; Yuji Matsumura; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Masayuki Chida
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

Review 4.  The Epidemiology and Risk Factors for Postoperative Pneumonia.

Authors:  Morad Chughtai; Chukwuweike U Gwam; Nequesha Mohamed; Anton Khlopas; Jared M Newman; Rafay Khan; Ali Nadhim; Shervin Shaffiy; Michael A Mont
Journal:  J Clin Med Res       Date:  2017-04-26

5.  Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: a systematic review and meta-analysis.

Authors:  Xiaohu Hao; Jianqi Hao; Cong Chen; Haoning Peng; Jian Zhang; Qi Cao; Lunxu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.